The antitrust and competition team at Cooley LLP is regularly instructed by clients in the life sciences and technology sectors, operating out of Washington, DC and working closely with colleagues in Chicago, San Diego, New York, London and Brussels on multijurisdictional merger control matters. The practice is jointly led from Washington DC by Jeremy Morrison, who advises clients from pre-merger planning through to post-closing investigations, with experience across the energy, transportation and retail sectors, and Megan Browdie, a go-to for merger review and agency investigations, particularly for technology and life sciences clients. Former practice head Ethan Glass has left the team.
Legal 500 Editorial commentary
Key clients
- 3SBio
- Battery Ventures
- BioNTech-BMS
- Boston Celtics and the Grousbeck Family
- Capstan Therapeutics
- Gynesonics
- io Products
- Jiangsu Hengrui Pharmaceuticals
- Kate Therapeutics
- Katy Hearn and Haydn Schneider co-founders of Alani Nutrition Battery
- Longboard Pharmaceuticals
- Poppi
Work highlights
Advised 3SBio on antitrust aspects of its up to $6 billion+ exclusive licensing agreement with Pfizer for the development, manufacture and commercialization of SSGJ-707.
Advised the Boston Celtics and the Grousbeck family in connection with the sale of the Celtics to an investor group.
Represented io Products, Inc. in its landmark $6.5 billion merger with OpenAI, marking OpenAI’s largest transaction to date.
Practice head
Megan Browdie; Jeremy Morrison